Skip to main content
Log in

IMPROVE-IT-Studie

LDL-Spiegel nach akutem Koronarsyndrom – „The lower, the better“?

IMPROVE-IT-Study

LDL-level after acute coronary syndrome – „The lower, the better?“

  • Journal Club
  • Published:
Der Kardiologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Baigent C, Keech A, Kearney PM et al (2005) Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90.056 participants in 14 randomised trials of statins. Lancet 366:1267–1278

    Article  CAS  PubMed  Google Scholar 

  2. Cannon CP, Blazing MA, Giugliano RP et al (2015) Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med 372:2387–2397

    Article  CAS  PubMed  Google Scholar 

  3. Stone NJ, Robinson JG, Lichtenstein AH et al (2014) 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 129:1–45

    Article  Google Scholar 

  4. Windecker S, Kolh P et al (2014) ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 35:2541–2619

    Article  PubMed  Google Scholar 

  5. Jarcho JA, Keaney JF, Jr. (2015) Proof That Lower Is Better--LDL Cholesterol and IMPROVE-IT. N Engl J Med 372:2448–2450

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Özcelik.

Ethics declarations

Interessenkonflikt

C. Özcelik und M. Gailani geben an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Özcelik, C., Gailani, M. IMPROVE-IT-Studie. Kardiologe 9, 329–331 (2015). https://doi.org/10.1007/s12181-015-0019-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12181-015-0019-3

Navigation